What are the current Australian guidelines for treating maxillary sinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Current Australian Guidelines for Management of Maxillary Sinusitis

Amoxicillin-clavulanate is the first-line antibiotic treatment for acute bacterial maxillary sinusitis in Australia, with a recommended dosage of 875/125 mg twice daily for 5-7 days in adults. 1

Diagnosis of Acute Bacterial Sinusitis

Diagnosis should be based on one of the following clinical patterns:

  • Persistent symptoms: Nasal discharge or cough persisting for >10 days without improvement 1
  • Severe symptoms: High fever (≥39°C/102.2°F) with purulent nasal discharge or facial pain for ≥3 consecutive days 1
  • Worsening symptoms: Initial improvement followed by worsening of symptoms ("double-sickening") 1

First-line Antibiotic Treatment

Adults:

  • First choice: Amoxicillin-clavulanate 875/125 mg twice daily for 5-7 days 1
  • High-dose option: Amoxicillin-clavulanate 2000/125 mg twice daily for 5-7 days (for areas with high pneumococcal resistance) 1

Children:

  • First choice: Amoxicillin-clavulanate at appropriate weight-based dosing 1
  • Alternative: Amoxicillin 45 mg/kg twice daily 1

Alternative Antibiotics (for penicillin allergy)

  • Cefuroxime: 250-500 mg twice daily for 5-7 days 1, 2
  • Cefpodoxime: 200-400 mg twice daily for 5-7 days 1
  • Cefdinir: 300-600 mg twice daily for 5-7 days 1
  • Levofloxacin: 500 mg once daily for 5-7 days (reserve for treatment failures or complicated cases) 1
  • Moxifloxacin: 400 mg once daily for 5-7 days (reserve for treatment failures or complicated cases) 1

Risk Factors for Resistant Organisms

Consider high-dose therapy or broader-spectrum antibiotics in patients with:

  • Age <2 or >65 years
  • Recent antibiotic use (within previous 30 days)
  • Recent hospitalization
  • Significant comorbidities
  • Immunocompromised state
  • Daycare attendance (pediatric patients)
  • Residence in areas with high prevalence of penicillin-resistant S. pneumoniae 3, 1

Adjunctive Treatments

  • Intranasal corticosteroids: Reduce inflammation and improve sinus drainage
  • Saline nasal irrigation: Helps clear mucus and reduce congestion
  • Analgesics: Acetaminophen or ibuprofen for pain and fever
  • Decongestants: Short-term use (3-5 days) of oral or topical decongestants 1

Treatment Monitoring and Follow-up

  • Assess for clinical improvement within 72 hours of starting antibiotics
  • If no improvement after 3-5 days, consider switching to a broader-spectrum antibiotic
  • Immediate specialist referral for signs of complications (orbital involvement, severe pain, persistent fever) 1

Surgical Intervention

  • Consider referral to an otolaryngologist if symptoms persist despite appropriate antibiotic therapy and adjunctive treatments
  • Surgical intervention may be necessary for persistent symptoms beyond 3 weeks despite antibiotic therapy 1

Common Pitfalls to Avoid

  • Overdiagnosis: Not all cases of sinusitis are bacterial; many are viral or allergic in origin
  • Inadequate duration: Ensure complete course of antibiotics (5-7 days)
  • Failure to address underlying conditions: Identify and treat allergic rhinitis or immunodeficiency
  • Delayed referral: Promptly refer patients with signs of complications or treatment failure
  • Antibiotic resistance: Be aware of local resistance patterns when selecting antibiotics 1

Microbiology Considerations

The major bacterial pathogens in acute bacterial sinusitis are:

  • Streptococcus pneumoniae (approximately 30%)
  • Haemophilus influenzae (approximately 30%)
  • Moraxella catarrhalis (approximately 10%)
  • About 25-30% of maxillary sinus aspirates may be sterile 3

Staphylococcus aureus is rarely isolated in uncomplicated acute bacterial sinusitis but is a significant pathogen in orbital and intracranial complications 3.

References

Guideline

Treatment of Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.